Company Quick10K Filing
TechPrecision
Price-0.00 EPS0
Shares29 P/E-0
MCap-0 P/FCF-0
Net Debt1 EBIT1
TEV1 TEV/EBIT1
TTM 2019-09-30, in MM, except price, ratios
10-Q 2020-06-30 Filed 2020-08-13
10-K 2020-03-31 Filed 2020-06-11
10-Q 2019-12-31 Filed 2020-02-13
10-Q 2019-09-30 Filed 2019-11-13
10-Q 2019-06-30 Filed 2019-08-13
10-K 2019-03-31 Filed 2019-06-27
10-Q 2018-12-31 Filed 2019-02-13
10-Q 2018-09-30 Filed 2018-11-13
10-Q 2018-06-30 Filed 2018-08-13
10-K 2018-03-31 Filed 2018-06-28
10-Q 2017-12-31 Filed 2018-02-13
10-Q 2017-09-30 Filed 2017-11-13
10-Q 2017-06-30 Filed 2017-08-14
10-K 2017-03-31 Filed 2017-06-29
10-Q 2016-12-31 Filed 2017-02-14
10-Q 2016-09-30 Filed 2016-11-14
10-Q 2016-06-30 Filed 2016-08-15
10-K 2016-03-31 Filed 2016-06-28
10-Q 2015-12-31 Filed 2016-02-16
10-Q 2015-09-30 Filed 2015-11-16
10-Q 2015-06-30 Filed 2015-08-14
10-K 2015-03-31 Filed 2015-06-29
10-Q 2014-12-31 Filed 2015-02-17
10-Q 2014-09-30 Filed 2014-11-14
10-Q 2014-06-30 Filed 2014-08-18
10-K 2014-03-31 Filed 2014-07-15
10-Q 2013-12-31 Filed 2014-02-13
10-Q 2013-09-30 Filed 2013-11-14
10-Q 2013-06-30 Filed 2013-09-18
10-K 2013-03-31 Filed 2013-08-16
10-Q 2012-12-31 Filed 2013-02-19
10-Q 2012-09-30 Filed 2012-11-21
10-Q 2012-06-30 Filed 2012-08-14
10-K 2012-03-31 Filed 2012-07-16
10-Q 2011-12-31 Filed 2012-02-14
10-Q 2011-09-30 Filed 2011-11-14
10-Q 2011-06-30 Filed 2011-08-15
10-K 2011-03-31 Filed 2011-06-29
10-Q 2010-12-31 Filed 2011-02-14
10-Q 2010-09-30 Filed 2010-11-15
10-Q 2010-06-30 Filed 2010-08-13
10-K 2010-03-31 Filed 2010-06-29
10-Q 2009-12-31 Filed 2010-02-16
8-K 2020-08-13 Earnings, Exhibits
8-K 2020-06-11
8-K 2020-05-08
8-K 2020-02-13
8-K 2020-01-16
8-K 2019-11-13
8-K 2019-09-10
8-K 2019-08-13
8-K 2019-06-27
8-K 2019-03-15
8-K 2019-02-13
8-K 2018-12-19
8-K 2018-12-07
8-K 2018-11-13
8-K 2018-09-12
8-K 2018-08-13
8-K 2018-07-18
8-K 2018-06-28
8-K 2018-06-06
8-K 2018-05-08
8-K 2018-02-13

TPCS 10Q Quarterly Report

Part I
Item 1. Financial Statements
Note 1 - Description of Business
Note 2 - Basis of Presentation and Significant Accounting Policies
Note 3 - Accounting Standards Update
Note 4 - Revenue
Note 5 - Income Taxes
Note 6 - Earnings per Share
Note 7 - Stock - Based Compensation
Note 8 - Concentration of Credit Risk
Note 9 - Other Current Assets
Note 10 - Accrued Expenses
Note 11 - Debt
Note 12 - Leases
Note 13 - Commitments
Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations
Item 3. Quantitative and Qualitative Disclosure About Market Risk.
Item 4. Controls and Procedures.
Part II. Other Information.
Item 6. Exhibits.
EX-31.1 tm2024714d1_ex31-1.htm
EX-31.2 tm2024714d1_ex31-2.htm
EX-32.1 tm2024714d1_ex32-1.htm

TechPrecision Earnings 2020-06-30

Balance SheetIncome StatementCash Flow
25201510502012201420172020
Assets, Equity
10.07.54.92.4-0.2-2.72012201420172020
Rev, G Profit, Net Income
2.51.70.8-0.0-0.9-1.72012201420172020
Ops, Inv, Fin

10-Q 1 tm2024714d1_10q.htm FORM 10-Q

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended June 30, 2020

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from __________________ to __________________

 

Commission File Number: 000-51378

 

TechPrecision Corporation

 

(Exact name of registrant as specified in its charter)

 

Delaware   51-0539828
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

1 Bella Drive    
Westminster, MA   01473
(Address of principal executive offices)   (Zip Code)
     
Registrant’s telephone number, including area code   (978) 874-0591

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.

x Yes ¨ No

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

x Yes ¨ No

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company”, and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

Large accelerated filer ¨     Accelerated filer ¨
Non-accelerated filer x     Smaller reporting company x
Emerging growth company ¨        

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards pursuant to Section 13(a) of the Exchange Act.       ¨

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

¨ Yes x No

 

The number of shares outstanding of the registrant’s common stock as of August 7, 2020 was 29,398,662.

 

 

 

 

 

 

TABLE OF CONTENTS

 

 

 2 

 

 

PART I

ITEM 1. FINANCIAL STATEMENTS

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED BALANCE SHEETS (unaudited)

 

   June 30,
2020
   March 31,
2020
 
ASSETS          
Current assets:          
Cash and cash equivalents  $1,802,039   $930,856 
Accounts receivable, net   916,529    990,300 
Contract assets   5,197,463    4,504,621 
Raw materials   558,357    561,572 
Work-in-process   739,090    656,041 
Other current assets   418,890    606,151 
Total current assets   9,632,368    8,249,541 
Property, plant and equipment, net   4,055,392    4,182,861 
Deferred income taxes   2,152,840    2,115,480 
Other noncurrent assets, net   21,369    32,600 
Total assets  $15,861,969   $14,580,482 
           
LIABILITIES AND STOCKHOLDERS’ EQUITY:          
Current liabilities:          
Accounts payable  $555,979   $185,065 
Accrued expenses   1,528,531    1,554,524 
Contract liabilities   516,337    805,049 
Current portion of long-term debt   621,251    109,829 
Total current liabilities   3,222,098    2,654,467 
Long-term debt   3,231,247    2,456,560 
Commitments and contingent liabilities (Note 13)          
Stockholders’ Equity:          
Common stock - par value $.0001 per share, 90,000,000 shares authorized, 29,398,662 and 29,354,594 shares issued and outstanding, at June 30, 2020 and March 31, 2020   2,939    2,935 
Additional paid in capital   8,848,558    8,793,062 
Accumulated other comprehensive income   21,591    21,688 
Retained earnings   535,536    651,770 
Total stockholders’ equity   9,408,624    9,469,455 
Total liabilities and stockholders’ equity  $15,861,969   $14,580,482 

 

See accompanying notes to the condensed consolidated financial statements.

 

 3 

 

 

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE (LOSS) INCOME (unaudited)

 

   Three months ended June 30, 
   2020   2019 
Net sales  $3,282,525   $4,334,268 
Cost of sales   2,585,511    3,224,767 
Gross profit   697,014    1,109,501 
Selling, general and administrative   793,362    741,413 
(Loss) income from operations   (96,348)   368,088 
Other income   652    19,430 
Interest expense   (57,898)   (76,523)
Total other expense, net   (57,246)   (57,093)
(Loss) income before income taxes   (153,594)   310,995 
Income tax (benefit) expense   (37,360)   90,218 
Net (loss) income  $(116,234)  $220,777 
Other comprehensive loss:          
Foreign currency translation adjustments   (97)   (179)
Other comprehensive loss, net of tax   (97)   (179)
Comprehensive (loss) income  $(116,331)  $220,598 
Net (loss) income per share – basic  $(0.01)  $0.01 
Net (loss) income per share – diluted  $(0.01)  $0.01 
Weighted average number of shares outstanding – basic   29,359,921    29,253,495 
Weighted average number of shares outstanding – diluted   29,359,921    30,711,007 

 

See accompanying notes to the condensed consolidated financial statements.

 

 4 

 

 

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (unaudited)

 

   Common
Stock
Outstanding
   Par
Value
   Additional
Paid in
Capital
   Accumulated
Other
Comprehensive
Income
   Retained
Earnings
   Total
Stockholders’
Equity
 
Balance 3/31/2019   29,234,594   $2,923   $8,693,106   $21,940   $993,339   $9,711,308 
Non-vested restricted stock             30,625              30,625 
Shares issued under LTIP   20,000    2    7,198              7,200 
Net income                       220,777    220,777 
Foreign currency translation adjustment                  (179)        (179)
Balance 6/30/2019   29,254,594   $2,925   $8,730,929   $21,761   $1,214,116   $9,969,731 
                               
Balance 3/31/2020   29,354,594   $2,935   $8,793,062   $21,688   $651,770   $9,469,455 
Non-vested restricted stock             55,500              55,500 
Shares issued under LTIP   44,068    4    (4)             -- 
Net loss                       (116,234)   (116,234)
Foreign currency translation adjustment                  (97)        (97)
Balance 6/30/2020   29,398,662   $2,939   $8,848,558   $21,591   $535,536   $9,408,624 

 

See accompanying notes to the condensed consolidated financial statements.

 

 5 

 

 

TECHPRECISION CORPORATION

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (unaudited)

 

   Three Months Ended June 30, 
   2020   2019 
CASH FLOWS FROM OPERATING ACTIVITIES          
Net (loss) income  $(116,234)  $220,777 
Adjustments to reconcile net (loss) income to net cash provided by operating activities:          
Depreciation   169,237    190,005 
Amortization of debt issue costs   15,141    10,741 
Stock based compensation expense   55,500    30,625 
Change in contract loss provision   (64,699)   120,393 
Deferred income taxes   (37,360)   90,218 
Changes in operating assets and liabilities:          
Accounts receivable   73,771    144,381 
Contract assets   (692,842)   1,517,221 
Inventories   (79,834)   38,517 
Other current assets   187,261    78,219 
Accounts payable   370,914    (342,639)
Accrued expenses   38,614    5,915 
Contract liabilities   (288,712)   (401,097)
Net cash (used in) provided by operating activities   (369,243)   1,703,276 
CASH FLOWS FROM INVESTING ACTIVITIES          
Purchases of property, plant and equipment   (41,768)   (10,200)
Net cash used in investing activities   (41,768)   (10,200)
CASH FLOWS FROM FINANCING ACTIVITIES          
Debt issue costs   (8,282)   -- 
Proceeds from payroll protection program   1,317,100    -- 
Proceeds from revolver loan   1,000,000    -- 
Repayment of revolver loan   (1,000,000)   -- 
Repayment of long-term debt   (26,618)   (199,533)
Net cash provided by (used in) financing activities   1,282,200    (199,533)
Effect of exchange rate on cash and cash equivalents   (6)   164 
Net increase in cash and cash equivalents   871,183    1,493,707 
Cash and cash equivalents, beginning of period   930,856    2,036,646 
Cash and cash equivalents, end of period  $1,802,039   $3,530,353 
SUPPLEMENTAL DISCLOSURES OF CASH FLOWS INFORMATION          
Cash paid during the year for:          
Interest  $40,024   $65,723 
Income taxes  $--   $-- 

 

See accompanying notes to the condensed consolidated financial statements.

 

SUPPLEMENTAL INFORMATION - NONCASH INVESTING AND FINANCING TRANSACTIONS:

 

Three months ended June 30, 2020

 

On June 13, 2020, our executive officers exercised options to purchase 150,000 shares of the Company’s common stock, par value $0.0001 per share, in a cashless transaction, pursuant to option awards granted under the Company’s 2016 Long-Term Incentive Plan.

 

 6 

 

 

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 - DESCRIPTION OF BUSINESS

 

TechPrecision Corporation, or TechPrecision, is a Delaware corporation organized in February 2005 under the name Lounsberry Holdings II, Inc. The name was changed to TechPrecision Corporation on March 6, 2006. TechPrecision is the parent company of Ranor, Inc., or Ranor, a Delaware corporation, and Wuxi Critical Mechanical Components Co., Ltd., or WCMC, a wholly foreign owned enterprise. WCMC has no customers or operations, and we have initiated a plan of termination to legally dissolve this subsidiary. TechPrecision, WCMC and Ranor are collectively referred to as the “Company”, “we”, “us” or “our”.

 

We manufacture large-scale metal fabricated and machined precision components and equipment. These products are used in a variety of markets including defense and aerospace, nuclear, medical, and precision industrial. We consider our business to consist of one segment - metal fabrication and precision machining. All of our operations and customers are located in the United States.

 

NOTE 2 - BASIS OF PRESENTATION AND SIGNIFICANT ACCOUNTING POLICIES

 

Basis of Presentation and Consolidation - The accompanying condensed consolidated financial statements include the accounts of TechPrecision, Ranor and WCMC. Intercompany transactions and balances have been eliminated in consolidation. The accompanying condensed consolidated balance sheets as of June 30, 2020 and March 31, 2020, the condensed consolidated statements of operations and comprehensive (loss) income and stockholders’ equity for the three months ended June 30, 2020 and 2019, and the condensed consolidated statements of cash flows for the three months ended June 30, 2020 and 2019 are unaudited, but, in the opinion of management, include all adjustments that are necessary for a fair presentation of our financial statements for interim periods in accordance with U.S. Generally Accepted Accounting Principles, or U.S. GAAP. All adjustments are of a normal, recurring nature, except as otherwise disclosed. The results of operations for an interim period are not necessarily indicative of the results of operations to be expected for the fiscal year.

 

These notes to the condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission, or the SEC, for Quarterly Reports on Form 10-Q. Certain information and disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to such rules and regulations. These unaudited financial statements and related notes should be read in conjunction with the consolidated financial statements included with our Annual Report on Form 10-K for the fiscal year ended March 31, 2020, or the 2020 Form 10-K, filed with the SEC on June 11, 2020.

 

Use of Estimates in the Preparation of Financial Statements - In preparing the condensed consolidated financial statements in conformity with U.S. GAAP, management is required to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements and revenues and expenses during the reported period. We continually evaluate our estimates, including those related to contract accounting, accounts receivable, inventories, the recovery of long-lived assets, income taxes and the valuation of equity transactions. We base our estimates on historical and current experiences and on various other assumptions that we believe to be reasonable under the circumstances. Actual results could differ from those estimates.

 

The COVID-19 pandemic has negatively affected certain customers, suppliers and their labor force. For example, travel restrictions in connection with the pandemic have delayed inspections, deliveries and impacted some supply chain providers. The future financial impact of the COVID-19 pandemic cannot be reasonably estimated at this time as its impact depends on future developments, which are highly uncertain and cannot be predicted.

 

The directives imposed by federal, state and local governments as a result of the COVID-19 pandemic did not impair our ability to maintain operations during the first quarter of fiscal 2021 as the Company was designated an essential service. Our estimates at the end of the first quarter assumed no material impact from the disruptions caused by COVID-19.

 

NOTE 3 – ACCOUNTING STANDARDS UPDATE

 

New Accounting Standards Recently Adopted

 

On April 1, 2020 we adopted ASU 2018-13, Fair Value Measurement (Topic 820): Disclosure Framework-Changes to the Disclosure Requirements for Fair Value Measurement.  This ASU modifies the disclosure requirements in Topic 820 by removing, modifying or adding certain disclosures.  The amendments for changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty are applied prospectively.  All other amendments are applied retrospectively to all periods presented upon their effective date.  The adoption did not have a significant impact on our consolidated financial statement disclosures.

 

 7 

 

 

Issued Standards Not Yet Adopted

 

In December, 2019, the FASB issued ASU No. 2019-12, Income Taxes (Topic 740): Simplifying the Accounting for Income Taxes, expected to reduce cost and complexity related to the accounting for income taxes. This ASU removes specific exceptions to the general principles in Topic 740 under U.S. GAAP and removes the limitation on the tax benefit recognized on pre-tax losses in interim periods. This guidance is effective for fiscal years, and interim periods within those years, beginning after December 15, 2020. The Company is currently evaluating the amendments in this update to determine the impact it may have on its financial statements and disclosures.

 

NOTE 4 - REVENUE

 

The Company generates its revenues primarily from performance obligations completed under contracts with customers in two main market sectors: defense and precision industrial. The period over which the Company performs ranges from three to thirty-six months. The Company invoices and receives related payments based upon performance progress not less frequently than monthly.

 

Revenue is recognized over-time or at a point-in-time given the terms and conditions of the related contracts. The Company utilizes an inputs methodology based on estimated labor hours to measure performance progress. This model best depicts the transfer of control to the customer.

 

The Company’s contract portfolio is comprised of fixed-price contracts and provide for product type sales only. The following table presents net sales on a disaggregated basis by market and contract type:

 

Net Sales by market  Defense   Industrial   Totals 
Three months ended June 30, 2020  $3,203,590   $78,935   $3,282,525 
Three months ended June 30, 2019  $3,409,291   $924,977   $4,334,268 

 

Net Sales by contract type   Over-time    Point-in-time    Totals 
Three months ended June 30, 2020  $3,027,897    254,628   $3,282,525 
Three months ended June 30, 2019  $3,052,938    1,281,330   $4,334,268 

 

As of June 30, 2020, the Company had $14.4 million of remaining performance obligations, of which $11.3 million were less than 50% complete. The Company expects to recognize all of its remaining performance obligations as revenue within the next three to thirty-six months.

 

We have been dependent in each year on a small number of customers who generate a significant portion of our business, and these customers can change from year to year. The following table sets forth information as to net sales from customers who accounted for more than 10% of our net sales for the three months ended:

 

   June 30, 2020   June 30, 2019 
Customer  Amount   Percent   Amount   Percent 
A  $1,014,655    31%  $*      *%
B  $654,187    20%  $*      *%
C  $570,780    17%  $1,050,577    24%
D  $390,512    12%  $ *      *%
E  $ *    *%  $1,255,055    29%
F  $*    *%  $618,019    14%
G  $*    *%  $549,192    13%

*Less than 10% of total

 

On our condensed consolidated balance sheet, contract assets and contract liabilities are reported in a net position on a contract-by-contract basis at the end of each reporting period. In fiscal 2021, we recognized revenue of $0.4 million related to our contract liabilities at March 31, 2020. At June 30, 2020 contract assets consisted of the following:

 

Contract assets  Unbilled   Progress
payments
   Total 
June 30, 2020  $9,104,826   $(3,907,363)  $5,197,463 
March 31, 2020  $10,635,588   $(6,130,967)  $4,504,621 

 

 8 

 

 

NOTE 5 - INCOME TAXES

 

We account for income taxes under the provisions of FASB ASC 740, Income Taxes.  The tax provision for interim periods is determined using the estimated annual effective consolidated tax rate, based on the current estimate of full-year earnings before taxes, adjusted for the impact of discrete quarterly items. The income tax benefit was $37,360 for the three months ended June 30, 2020 and the provision for income taxes was $90,218 for the three months ended June 30, 2019. The Company's estimated effective tax rates for the three months ended June 30, 2020 and 2019 was 24.3% and 29.0%, respectively.

 

The valuation allowance on deferred tax assets was approximately $1.8 million at June 30, 2020. We believe that it is more likely than not that the benefit from certain state and foreign net operating losses, or NOL, carryforwards and other deferred tax assets will not be realized. In the event future taxable income is below management’s estimates or is generated in tax jurisdictions different than projected, the Company could be required to increase the valuation allowance for deferred tax assets. This would result in an increase in the Company’s effective tax rate.

 

NOTE 6 - EARNINGS PER SHARE

 

Basic earnings per share is computed by dividing reported earnings available to stockholders by the weighted average number of shares outstanding. Diluted earnings per share includes the effect of stock options that would be dilutive. The following table provides a reconciliation of the numerators and denominators reflected in the basic and diluted earnings per share computations, as required under FASB ASC 260.

 

   June 30, 2020   June 30, 2019 
Basic EPS          
Net (loss) income  $(116,234)  $220,777 
Weighted average shares   29,359,921    29,253,495 
Basic (loss) earnings per share  $(0.01)  $0.01 
Diluted EPS          
Net (loss) income  $(116,234)  $220,777 
Dilutive effect of stock options   --    1,457,512 
Diluted weighted average shares   29,359,921    30,711,007 
Diluted (loss) earnings per share  $(0.01)  $0.01 

 

All potential common stock equivalents that have an anti-dilutive effect (i.e. those that increase income per share or decrease loss per share) are excluded from the calculation of diluted earnings per share. For the three months ended June 30, 2020, there were 2,816,000 of potentially anti-dilutive stock options, none of which were included in the earnings per share calculations above. For the three months ended June 30, 2019 there were 98,000 of potential common stock equivalents that were out-of-the-money and not included in the above earnings per share calculations.

 

NOTE 7 - STOCK-BASED COMPENSATION

 

Our board of directors approved the 2016 TechPrecision Equity Incentive Plan, or the 2016 Plan, on November 10, 2016. Our stockholders approved the 2016 Plan at the Company’s Annual Meeting of Stockholders on December 8, 2016. The 2016 Plan succeeds the 2006 Plan and applies to awards granted after the 2016 Plan’s adoption by the Company’s stockholders. The 2016 Plan provides for a share reserve of 5,000,000 shares of common stock.

 

The 2016 Plan authorizes the award of incentive and non-qualified stock options, restricted stock awards, restricted stock units, and performance awards to employees, directors, consultants, and other individuals who provide services to TechPrecision or its affiliates.

 

At June 30, 2020 and March 31, 2020, there were 1,474,000 shares available for grant under the 2016 Plan. The following table summarizes information about options granted during the two most recently completed periods:

 

   Number Of   Weighted
Average
   Aggregate
Intrinsic
   Weighted
Average
Remaining
Contractual Life
 
   Options   Exercise Price   Value   (in years) 
Outstanding at 3/31/2019   2,938,000   $0.416   $1,869,200    6.74 
Exercised   (20,000)   0.360           
Canceled   (2,000)               
Outstanding at 3/31/2020   2,916,000   $0.415   $2,546,800    6.21 
Exercised   (150,000)   0.800           
Outstanding at 6/30/2020   2,766,000   $0.394   $2,289,400    6.13 
Vested or expected to vest at 6/30/2020   2,766,000   $0.394   $2,289,400    6.13 
Exercisable and vested at 6/30/2020   2,766,000   $0.394   $2,289,400    6.13 

 

 9 

 

 

The aggregate intrinsic value in the table above represents the total pre-tax intrinsic value (the difference between the closing stock price on the last trading day of the first quarter of fiscal 2021 and the exercise price, multiplied by the number of in-the-money options) that would have been received by the option holders had all option holders exercised their options on June 30, 2020. This amount changes based on the fair market value of the Company’s common stock.

 

At June 30, 2020, there was no remaining unrecognized compensation cost related to stock options. The maximum contractual term is ten years for option grants. Other information relating to stock options outstanding at June 30, 2020 is as follows:

 

Range of Exercise Prices:  Options
Outstanding
   Weighted
Average
Remaining
Contractual
Term
   Weighted
Average
Exercise Price
   Options
Exercisable
   Weighted
Average
Exercise Price
 
$0.01-$1.00   2,670,000    6.37   $0.34    2,670,000   $0.34 
$1.01-$1.96   96,000    0.69   $1.84    96,000   $1.84 
Totals   2,766,000              2,766,000      

 

Restricted Stock Awards

 

On March 16, 2020 we granted a total of 100,000 shares of restricted stock under the 2016 Plan to the board of directors. The stock-based compensation expense of $111,000 for service-based restricted stock was measured at fair value on the date of grant based on the number of shares expected to vest and the quoted market price of the Company’s common stock. The shares of restricted stock fully vest and cease to be subject to forfeiture on September 1, 2020, or approximately six months following the grant date. Each grantee must be serving as a director on the vesting date and must have been continuously serving in such capacity from the grant date through the vesting date for the shares of restricted stock to vest. Prior to the vesting date, the grantee is not permitted to sell, transfer, pledge, assign or otherwise encumber the shares of restricted stock and if the grantee’s service with the Company terminates prior to the vesting date, the grantee’s restricted stock will be forfeited automatically. Total recognized compensation cost related to the restricted stock award was $55,500 for the three months ended June 30, 2020. At June 30, 2020 there was $46,250 of total unrecognized compensation cost related to the restricted stock awards.

 

NOTE 8 - CONCENTRATION OF CREDIT RISK

 

We maintain bank account balances, which, at times, may exceed insured limits. We have not experienced any losses with these accounts and believe that we are not exposed to any significant credit risk on cash.

 

At June 30, 2020, there were trade accounts receivable balances outstanding from four customers comprising 91% of the total trade receivables balance. The following table sets forth information as to trade accounts receivable from customers who accounted for more than 10% of our accounts receivable balance as of:

 

   June 30, 2020   March 31, 2020 
Customer  Dollars   Percent   Dollars   Percent   
A  $349,460    38%  $*       * 
B  $258,872    28%  $*       * 
C  $140,599    15%  $*       * 
D  $93,600    10%  $254,637    26%
E  $*       *   $365,636    37%
F  $*       *   $123,000    12%

*less than 10% of total

 

 10 

 

 

NOTE 9 - OTHER CURRENT ASSETS

 

   June 30, 2020   March 31, 2020 
Payments advanced to suppliers  $131,643   $272,070 
Prepaid insurance   194,649    250,073 
Prepaid subscriptions   20,273    14,440 
Refundable AMT credits   22,748    22,748 
Employee advances   24,079    18,173 
Other   25,498    28,647 
Total  $418,890   $606,151 

 

NOTE 10 - ACCRUED EXPENSES

 

   June 30, 2020   March 31, 2020 
Provision for claims settlement  $495,000   $495,000 
Accrued compensation   507,064    383,555 
Provision for contract losses   220,781    285,480 
Accrued professional fees   212,805    279,657 
Accrued project costs   55,746    76,059 
Other   37,135    34,773 
Total  $1,528,531   $1,554,524 

 

Accrued compensation includes amounts for executive bonuses, payroll and vacation and holiday pay. Provisions for estimated losses on uncompleted contracts are made in the period in which such losses are determined. Changes in the provision are recorded in cost of sales. Accrued project costs are estimates for certain project expenses during the reporting period.

 

NOTE 11 - DEBT

 

Total debt included the following as of:  June 30, 2020   March 31, 2020 
Berkshire Term Loan at 5.21% interest, due January 2022  $2,540,646   $2,564,389 
Berkshire SBA PPP loan at 1% interest, due May 2022   1,317,100    -- 
Finance lease obligations at 8% interest, due January 2022   19,585    22,460 
Total debt  $3,877,331   $2,586,849 
Less: debt issue costs unamortized  $24,833   $20,460 
Total debt, net  $3,852,498   $2,566,389 
Less: Current portion of long-term debt  $621,251   $109,829 
Total long-term debt, net  $3,231,247   $2,456,560 

 

Small Business Administration Loan

 

On May 8, 2020, the Company, through its wholly owned subsidiary Ranor, issued a promissory note, or the Note, evidencing an unsecured loan in the amount of $1,317,100 made to Ranor under the Paycheck Protection Program, or the PPP. The PPP was established under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, and is administered by the U.S. Small Business Administration, or the SBA. The loan to Ranor was made through Berkshire Bank.

 

The Note provides for an interest rate of 1.00% per year and matures two years after the issuance date. Principal and accrued interest are payable monthly in equal installments commencing on the date that is six months after the date funds are first disbursed on the loan and continuing through the maturity date, unless the Note is forgiven as described below. To be available for loan forgiveness, the Note may only be used for payroll costs, costs related to certain group health care benefits and insurance premiums, rent payments, utility payments, mortgage interest payments and interest payments on any other debt obligations that existed before February 15, 2020. The Note may be prepaid at any time prior to maturity with no prepayment penalties and contains events of default and other conditions customary for a Note of this type. For example, the Note contains events of default relating to, among other things, payment defaults, making materially false and misleading representations to the SBA or Berkshire Bank, or breaching the terms of the loan documents. The occurrence of an event of default may result in the repayment of all amounts outstanding, collection of all amounts owing from the Company, or the SBA or Berkshire Bank filing suit and obtaining judgment against the Company and/or Ranor.

 

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loan granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs, certain group health care benefits and insurance premiums, and any payments of mortgage interest, rent, and utilities. The terms of any forgiveness may also be subject to further requirements in any regulations and guidelines the SBA may adopt. While the Company currently believes that its use of the Note proceeds will meet the conditions for forgiveness under the PPP, no assurance is provided that the Company will obtain forgiveness of the Note in whole or in part.

 

 11 

 

 

Berkshire Term Loan Facility

 

On December 21, 2016, TechPrecision, through Ranor, closed on a Loan Agreement, or the Berkshire Loan Agreement, with Berkshire Bank. Pursuant to the Berkshire Loan Agreement, Berkshire Bank made a term loan to Ranor in the amount of $2,850,000, or the Term Loan, and made available to Ranor a revolving line of credit under the Revolver Loan, or together, the Berkshire Loans. The Berkshire Loans are secured by a first lien on all personal and real property of Ranor.

 

On December 23, 2019, TechPrecision, through Ranor, entered into a Third Modification to Loan Agreement, or the Third Modification, and an Amended and Restated Promissory Note with Berkshire Bank. Under the Third Modification, Ranor and Berkshire agreed to increase the maximum principal amount available under the Revolver Loan from $1,000,000 to $3,000,000. Advances under the Revolver Loan are now subject to the lesser of (a) $3,000,000 or (b) the sum of (i) 80% of eligible accounts receivable, plus (ii) the lesser of (x) 25% of Eligible Raw Material Inventory, and (y) $250,000, plus (iii) 50% of the Appraised Value of the Eligible Equipment. The loan agreement is available for refinancing existing indebtedness and for working capital and general corporate purposes. Additionally, the parties agreed to lower the interest rate on advances made under the Revolver Loan at a variable rate equal to the one-month LIBOR plus 225 basis points.  The Third Modification contains customary LIBOR replacement provisions.

 

The Company borrowed $1.0 million under the Revolver Loan on April 3, 2020 and repaid principal of $1.0 million on June 30, 2020. There were no borrowed amounts outstanding under the Revolver Loan at June 30, 2020 and March 31, 2020. Interest payments on advances made under the Revolver Loan during the three months ended June 30, 2020 were $5,986 at a weighted average interest rate of 2.76%. Unused borrowing capacity at June 30, 2020 was $3.0 million, and the maturity date of the Revolver Loan is December 20, 2020.

 

The Berkshire Loan Agreement contains a covenant whereby the Company is required to maintain a debt service coverage ratio, or DSCR, of at least 1.2 to 1.0 during the term of the Berkshire Loans.  The DSCR is measured at the end of each fiscal quarter of the Company.  The Company was in compliance with all of the financial covenants at June 30, 2020 and March 31, 2020.

 

The Berkshire Loan Agreement also contains covenants to cause its balance sheet leverage to be less than or equal to 2.50 to 1.00 for each fiscal year end, and require Ranor to maintain a loan-to-value ratio of not greater than 0.75 to 1.00, to be measured by appraisal not more frequently than one time during each 365-day period.

 

Finance Lease

 

See Note 12 for information regarding our obligations under the finance lease.

 

Fair Value Measurements

 

We account for fair value measurements in accordance with ASC Topic 820, Fair Value Measurement, which defines fair value and establishes a framework to measure fair value and the related disclosures about fair value. The carrying value of short and long-term borrowings approximates their fair value at June 30, 2020 and March 31, 2020. The fair value of the long-term debt was calculated based on interest rates available for debt with terms and maturities similar to the Company's existing debt arrangements. The Company’s short-term and long-term debt with Berkshire bank is privately held with no public market for the debt and is considered to be Level 3 under the fair value hierarchy.

 

NOTE 12 – LEASES

 

Leases that are economically similar to the purchase of an asset are classified as finance leases. The leased, or right-of-use assets in finance lease arrangements are reported in net property, plant and equipment on our condensed consolidated balance sheet. Right-of-use assets and liabilities on our condensed consolidated balance sheet at June 30, 2020 were:

 

Finance lease:  June 30, 2020 
Property, plant and equipment  $54,376 
Accumulated depreciation   38,063 
Net property, plant and equipment  $16,313 
Current portion of long-term debt  $12,084 
Long-term debt  $7,501 
Total finance lease liabilities  $19,585 

 

 12 

 

 

In December 2019, we signed an operating lease for office space that expires in less than 12 months and is amortized on a straight line basis. Other supplemental information regarding our leases are contained in the following tables:

 

Components of lease expense for the period ended:  June 30, 2020 
Operating lease amortization  $949 
Finance lease amortization  $2,719 
Finance lease interest  $2,674 

 

Weighted average lease term and discount rate at:  June 30, 2020 
Finance lease term (years)   1.75 
Finance lease rate   8%

 

Supplemental cash flow information related to leases for the period ended:  June 30, 2020 
Cash used in operating activities  $949 
Cash used in financing activities  $2,875 

 

NOTE 13 - COMMITMENTS

 

Retirement Benefits

 

Ranor has a defined contribution and savings plan that covers substantially all Ranor employees who have completed 90 days of service. Ranor retains the option to match employee contributions. The Company contributed $20,725 and $20,073 for the three months ended June 30, 2020 and 2019, respectively.

 

Provision for claims settlement

 

On March 16, 2020, the Company reached an agreement to settle all outstanding claims for $495,000 related to a civil action brought by former employees for past wages claimed under a paid time-off program. The claim is to be paid within sixty days following Court approval of the settlement.

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

Statement Regarding Forward Looking Disclosure

 

The following discussion of the results of our operations and financial condition should be read in conjunction with our condensed consolidated financial statements and the related notes, which appear elsewhere in this Quarterly Report on Form 10-Q. This Quarterly Report on Form 10-Q, including this section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” may contain predictive or “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of current or historical fact contained in this quarterly report, including statements that express our intentions, plans, objectives, beliefs, expectations, strategies, predictions or any other statements relating to our future activities or other future events or conditions are forward-looking statements. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “predict,” “project,” “will,” “should,” “would” and similar expressions, as they relate to us, are intended to identify forward-looking statements.

 

These statements are based on current expectations, estimates and projections made by management about our business, our industry and other conditions affecting our financial condition, results of operations or business prospects. These statements are not guarantees of future performance and involve risks, uncertainties and assumptions that are difficult to predict. Therefore, actual outcomes and results may differ materially from what is expressed or forecasted in, or implied by, the forward-looking statements due to numerous risks and uncertainties. Factors that could cause such outcomes and results to differ include, but are not limited to, risks and uncertainties arising from:

 

· our reliance on individual purchase orders, rather than long-term contracts, to generate revenue;
· our ability to balance the composition of our revenues and effectively control operating expenses;
· external factors, including the COVID-19 pandemic, that may be outside of our control;
· the impacts of the COVID-19 pandemic and government-imposed lockdowns in response thereto;
· the availability of appropriate financing facilities impacting our operations, financial condition and/or liquidity;
· our ability to receive contract awards through competitive bidding processes;
· our ability to maintain standards to enable us to manufacture products to exacting specifications;
· our ability to enter new markets for our services;
· our reliance on a small number of customers for a significant percentage of our business;

 

13

 

  

· competitive pressures in the markets we serve;
· changes in the availability or cost of raw materials and energy for our production facilities;
· operating in a single geographic location;
· restrictions in our ability to operate our business due to our outstanding indebtedness;
· government regulations and requirements;
· pricing and business development difficulties;
· changes in government spending on national defense;
· our ability to make acquisitions and successfully integrate those acquisitions with our business;
· general industry and market conditions and growth rates;
· general economic conditions; and
· those risks discussed in “Item 1A. Risk Factors” and elsewhere in our 2020 Annual Report on Form 10-K, as well as those described in any other filings which we make with the SEC.

 

Any forward-looking statements speak only as of the date on which they are made, and we undertake no obligation to publicly update or revise any forward-looking statements to reflect events or circumstances that may arise after the date of this Quarterly Report on Form 10-Q, except as required by applicable law. Investors should evaluate any statements made by us in light of these important factors.

 

Overview

 

We offer a full range of services required to transform raw materials into precision finished products. Our manufacturing capabilities include: fabrication operations (cutting, press and roll forming, assembly, welding, heat treating, blasting and painting) and machining operations including CNC (computer numerical controlled) horizontal and vertical milling centers. We also provide support services to our manufacturing capabilities: manufacturing engineering (planning, fixture and tooling development, manufacturing), quality control (inspection and testing), materials procurement, production control (scheduling, project management and expediting) and final assembly.

 

All manufacturing is done in accordance with our written quality assurance program, which meets specific national and international codes, standards, and specifications. Ranor holds several certificates of authorization issued by the American Society of Mechanical Engineers and the National Board of Boiler and Pressure Vessel Inspectors. The standards used are specific to the customers’ needs, and our manufacturing operations are conducted in accordance with these standards.

 

Because our revenues are derived from the sale of goods manufactured pursuant to a contract, and we do not sell from inventory, it is necessary for us to constantly seek new contracts. There may be a time lag between our completion of one contract and commencement of work on another contract. During such periods, we may continue to incur overhead expense but with lower revenue resulting in lower operating margins. Furthermore, changes in either the scope of an existing contract or related delivery schedules may impact the revenue we receive under the contract and the allocation of manpower. Although we provide manufacturing services for large governmental programs, we usually do not work directly for the government or its agencies. Rather, we perform our services for large governmental contractors. Our business is dependent in part on the continuation of governmental programs which require our services and products.

 

Our contracts are generated both through negotiation with the customer and from bids made pursuant to a request for proposal. Our ability to receive contract awards is dependent upon the contracting party’s perception of such factors as our ability to perform on time, our history of performance, including quality, our financial condition and our ability to price our services competitively.  Although some of our contracts contemplate the manufacture of one or a limited number of units, we continue to seek more long-term projects with predictable cost structures.

 

Our results of operations are affected by a number of external factors including the availability of raw materials, commodity prices (particularly steel), macroeconomic factors, including the availability of capital that may be needed by our customers, and political, regulatory and legal conditions in the United States and in foreign markets. Generally, our projects are made up of short-term contracts with a production timeline of less than twelve months. However, some projects can take up to thirty-six months to complete. Units manufactured under the majority of our customer contracts are delivered on time and with a positive gross margin.  Our results of operations for any specific period are also affected by our success in booking new contracts, the timing of revenue recognition, delays in customer acceptances of our products, delays in deliveries of ordered products and our rate of progress fulfilling obligations under our contracts. A delay in deliveries or cancellations of orders could have an unfavorable impact on liquidity, cause us to have inventories in excess of our short-term needs, and delay our ability to recognize, or prevent us from recognizing, revenue on contracts in our order backlog.

 

14

 

  

At the end of March 2020, the outbreak of coronavirus (COVID-19) had spread worldwide as a pandemic. The full extent of the outbreak, related business and travel restrictions and changes to social behavior intended to reduce its spread remain uncertain and subject to change as the health crisis continues to evolve in the U.S. and abroad. The directives imposed by federal, state and local governments did not impair our ability to maintain operations during the first quarter of fiscal 2021 as the Company was designated an “Essential Service.” The pandemic has negatively affected certain of the Company’s customers, suppliers and labor force, and with the changing conditions as a result of the COVID-19 outbreak, the impact on our operations and financial results for the remainder of fiscal 2021 remains uncertain.

 

We and our customers have been designated essential services as national critical infrastructure companies by the U.S. Department of Homeland Security, We believe that the long term outlook for the defense industry remains positive as we continue to see meaningful opportunities in our defense sector, primarily in the nuclear submarine business for the next twelve months and beyond.

 

For the three months ended June 30, 2020, our net sales and net loss were $3.3 million and $0.1 million, respectively, compared with net sales of $4.3 million and net income of $0.2 million for the three months ended June 30, 2019.  Our gross margin for the three months ended June 30, 2020 and 2019 was 21.2% and 25.6%, respectively. We used $0.4 million of cash in operations for the three months ended June 30, 2020 and had a cash balance of $1.8 million at June 30, 2020.

 

For the three months ended June 30, 2020 and 2019, our largest customer in each period accounted for approximately 31% and 29% of reported net sales, respectively. For the three months ended June 30, 2020, we had four customers which accounted for approximately 80% of our revenue, in the aggregate. Our sales order backlog at June 30, 2020 and March 31, 2020 was approximately $14.4 million and $16.8 million, respectively.

 

Critical Accounting Policies

 

The preparation of the condensed consolidated financial statements requires that we make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. We base our estimates on historical experience and various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. We continually evaluate our estimates, including those related to revenue recognition, inventories, recovery of long-lived assets, income taxes and the valuation of equity transactions. These estimates and assumptions require management's most difficult, subjective or complex judgments. Actual results may differ under different assumptions or conditions.

 

Our significant accounting policies are set forth in detail in Note 2 to the consolidated financial statements included in the 2020 Annual Report on Form 10-K. We consider the policies relating to revenue recognition to be a critical accounting policy. There have been no significant changes to our critical accounting policies during the three months ended June 30, 2020.

 

Accounting Pronouncements

 

New Accounting Standards

 

See Note 3, Accounting Standards Update, in the Notes to the condensed consolidated financial statements in “Item 1. Financial Statements” for a discussion of recently adopted new accounting guidance and new accounting guidance not yet adopted.

 

Key Performance Indicators

 

While we prepare our financial statements in accordance with U.S. generally accepted accounting principles, or U.S. GAAP, we also utilize and present certain financial measures that are not based on or included in U.S. GAAP. We refer to these as Non-GAAP financial measures.  Please see the section “EBITDA Non-GAAP financial measure” below for further discussion of these financial measures, including the reasons why we use such financial measures and reconciliations of such financial measures to the most directly comparable U.S. GAAP financial measures.

 

Three Months Ended June 30, 2020 and 2019

 

The following table sets forth information from our condensed consolidated statements of operations and comprehensive (loss) income, in dollars and as a percentage of revenue:

 

   2020   2019   Changes 
(dollars in thousands)  Amount   Percent   Amount   Percent   Amount   Percent 
Net sales  $3,283    100%  $4,334    100%  $(1,051)   (24)%
Cost of sales   2,586    79%   3,224    74%   (638)   (20)%
Gross profit   697    21%   1,110    26%   (413)   (37)%
Selling, general and administrative   793    24%   742    17%   51    7%
Operating (loss) income   (96)   (3)%   368    8%   (464)   (126)%
Other expense, net   (57)   (2)%   (57)   (1)%   --    --%
(Loss) income before taxes   (153)   (5)%   311    7%   (464)   (149)%
Income tax (benefit) expense   (37)   (1)%   90    2%   (127)   (141)%
Net (loss) income  $(116)   (4)%  $221    5%  $(337)   (152)%

 

15

 

  

Net Sales

 

Changes in net sales generally reflect a different product mix and project volume when comparing the current and prior periods. Net sales were $3.3 million for the three months ended June 30, 2020, or 24% lower when compared to net sales for the three months ended June 30, 2019 of $4.3 million. For the three months ended June 30, 2020, net sales in our defense markets decreased by $0.2 million when compared to the three months ended June 30, 2019. However, our defense backlog remains strong as new orders for components continue to flow down from our prime defense contractors.

 

The Company records most of its revenue over time as it completes performance obligations. We measure progress for performance obligations satisfied over time using input methods (e.g., labor hours expended and time elapsed). Our fiscal 2021 first quarter revenues were impacted by a product mix that included certain projects with low margins which consumed a higher number of actual labor hours than originally estimated to complete. The higher actual labor hours had the effect of consuming more available hours, which could have been allocated to higher margin projects. This set of conditions resulted in lower revenue recognition in our defense markets during fiscal 2021 first quarter. Projects in-progress, with little or no margin, can slow turnover and result in lower revenue until they are completed.

 

Net sales to industrial markets decreased by $0.8 million when compared to the three months ended June 30, 2019. We have repeat business in this sector, but the order flow is uneven and difficult to forecast. Based on our current backlog, we anticipate higher revenue during the remainder of the fiscal year.

 

Cost of Sales and Gross Margin

 

Cost of sales consists primarily of raw materials, parts, labor, overhead and subcontracting costs. Our cost of sales for the three months ended June 30, 2020 were $2.6 million compared to $3.2 million for the three months ended June 30, 2019. Despite the decrease in dollars, our labor costs and factory overhead were higher as a percentage of revenue, due to the lower turnover. In addition, more labor hours were used on low margin projects during the period.

 

Gross margin was 21.2% for the three months ended June 30, 2020 and 25.6% for the three months ended June 30, 2019. Gross profit was $0.7 million for the three months ended June 30, 2020, or 37% lower when compared to the three months ended June 30, 2019.

 

Selling, General and Administrative Expenses

 

Total selling, general and administrative expenses for the three months ended June 30, 2020 increased by $51,949 due to an increase in salaries, stock-based compensation and outside advisory services which more than offset a decrease in travel expenses when compared to the three months ended June 30, 2019.

 

Other Expense, net

 

Interest expense was lower for the three months ended June 30, 2020 when compared to the three months ended June 30, 2019, and should continue to decrease as we amortize debt principal to maturity, barring any additional borrowings for working capital purposes under our revolving credit facility. Debt issue costs increased as the Company began to amortize costs associated with increasing the borrowing limit under the Revolver loan with Berkshire bank and borrowings under the payroll protection program, or PPP.

 

Other income for the three months ended June 30, 2019 included proceeds from the sale of machinery and equipment of $16,000. The following table reflects other income, interest expense and amortization of debt issue costs for the three months ended:

 

   June 30, 2020   June 30, 2019   $ Change   % Change 
Other income, net  $652   $19,430   $(18,778)       nm 
Interest expense  $(42,757)  $(65,782)  $23,025    35%
Amortization of debt issue costs  $(15,141)  $(10,741)  $(4,400)   (41)%

 

nm – not meaningful

 

16

 

  

Income Taxes

 

For the three months ended June 30, 2020 we recorded a tax benefit of $37,360 compared to tax expense of $90,218 for the three months ended June 30, 2019. Tax benefit for the three months ended June 30, 2020 was the result of an operating loss.

 

The valuation allowance on deferred tax assets at June 30, 2020 was approximately $1.8 million. We believe that it is more likely than not that the benefit from certain state and foreign NOL carryforwards and other deferred tax assets will not be realized. In recognition of this risk, we continue to provide a valuation allowance on these items. In the event future taxable income is below management’s estimates or is generated in tax jurisdictions different than projected, the Company could be required to increase the valuation allowance for deferred tax assets. This would result in an increase in the Company’s effective tax rate.

 

Net (Loss) Income

 

As a result of the foregoing, for the three months ended June 30, 2020, we recorded a net loss of $0.1 million, compared with net income of $0.2 million, for the three months ended June 30, 2019.

 

Liquidity and Capital Resources

 

On May 8, 2020, the Company, through its wholly owned subsidiary Ranor, Inc., issued a promissory note, or the Note, evidencing an unsecured loan in the amount of $1,317,100 made to Ranor under the Paycheck Protection Program, or the PPP. The PPP was established under the Coronavirus Aid, Relief, and Economic Security Act, or the CARES Act, and is administered by the U.S. Small Business Administration, or the SBA. The loan to Ranor was made through Berkshire Bank.

 

The Note provides for an interest rate of 1.00% per year and matures two years after the issuance date. Principal and accrued interest are payable monthly in equal installments commencing on the date that is six months after the date funds are first disbursed on the loan and continuing through the maturity date, unless the Note is forgiven as described below. To be available for loan forgiveness, the Note may only be used for payroll costs, costs related to certain group health care benefits and insurance premiums, rent payments, utility payments, mortgage interest payments and interest payments on any other debt obligation that existed before February 15, 2020. The Note may be prepaid at any time prior to maturity with no prepayment penalties and contains events of default and other conditions customary for a Note of this type.

 

Under the terms of the CARES Act, PPP loan recipients can apply for and be granted forgiveness for all or a portion of loan granted under the PPP, with such forgiveness to be determined, subject to limitations, based on the use of the loan proceeds for payment of payroll costs, certain group health care benefits and insurance premiums, and any payments of mortgage interest, rent, and utilities. The terms of any forgiveness may also be subject to further requirements in any regulations and guidelines the SBA may adopt. While the Company currently believes that its use of the Note proceeds will meet the conditions for forgiveness under the PPP, no assurance is provided that the Company will obtain forgiveness of the Note in whole or in part.

 

We also have a revolving line of credit with Berkshire Bank available as a resource, if necessary. The Company borrowed $1.0 million under the Revolver Loan on April 3, 2020 and repaid that principal on June 30, 2020. There were no borrowed amounts outstanding under the Revolver Loan at June 30, 2020 and March 31, 2020. Interest-only payments on advances made under the Revolver Loan during the three months ended June 30, 2020 totaled $5,986 at a weighted average interest rate of 2.76%. Unused borrowing capacity at June 30, 2020 was $3.0 million. The maturity date of the Revolver Loan is December 20, 2020.

 

At June 30, 2020, we had cash and cash equivalents of $1.8 million and working capital of $6.4 million. We believe our available cash plus cash expected to be provided by operations during fiscal 2021, and borrowing capacity available under the Revolver Loan will be sufficient to fund our operations, capital expenditures and principal and interest payments under our debt obligations through the 12 months from the issuance date of our financial statements.

 

The table below presents selected liquidity and capital measures for the period ended:

 

(dollars in thousands)   June 30, 2020     March 31, 2020     Change
Amount
 
Cash and cash equivalents   $ 1,802     $ 931     $ 871  
Working capital   $ 6,410     $ 5,595     $ 815  
Total debt   $ 3,877     $ 2,587     $ 1,290  
Total stockholders’ equity   $ 9,409     $ 9,469     $ (60 )

 

17

 

 

The following table summarizes the primary components of cash flows for the three months ended:

 

(dollars in thousands)  June 30, 2020   June 30, 2019   Change
Amount
 
Cash flows provided by (used in):               
Operating activities  $(369)  $1,703   $(2,072)
Investing activities   (42)   (10)   (32)
Financing activities   1,282    (199)   1,481 
Net increase in cash  $871   $1,494   $(623)

 

Operating activities

 

Our primary sources of cash are from accounts receivable collections, customer advance payments and project progress payments. Our customers make advance payments and progress payments under the terms of each manufacturing contract. Our cash flows can fluctuate significantly from period to period as the composition of our receivables collections mix changes between advance payments and customer payments made after shipment of finished goods. Cash used in operations for the three months ended June 30, 2020 was $0.4 million compared with cash provided by operations of $1.7 million for fiscal 2020, a decrease of $2.1 million.

 

During our first quarter of fiscal 2021 we encountered some delayed inspections, deliveries, and disrupted supply chain, due to travel restrictions in connection with the COVID-19 pandemic. In addition, we expended more direct labor hours on low margin projects. All of these events resulted in lower turnover when compared to the same quarter a year ago. Our first quarter of fiscal 2020 was marked by favorable timing with project completions and customer delivery schedules which generated higher amounts of cash.

 

Investing activities

 

We anticipate that we will spend approximately $0.5 million in new factory machinery and equipment during the remainder of fiscal 2021. Net cash used in investing activities for purchases of property, plant and equipment in the three months ended June 30, 2020 and 2019 totaled $41,768 and $10,200, respectively.

 

Financing activities

 

On May 8, 2020 we borrowed $1.3 million under the CARES Act payroll protection program. On April 3, 2020 we borrowed $1.0 million under our Revolver loan, then paid down $1.0 million in principal on June 30, 2020.

 

For the three months ended June 30, 2020 and 2019 we made monthly principal payments of $26,618 and $199,533 in connection with our term debt and finance lease obligations.

 

All of the above activity resulted in a net increase in cash of $0.9 million for the three months ended June 30, 2020 compared with a increase in cash of $1.5 million for the three months ended June 30, 2019.

 

Off-Balance Sheet Arrangements

 

We do not currently have, and have not had, any off-balance sheet assets, liabilities or arrangements at June 30, 2020.

 

EBITDA Non-GAAP Financial Measure

 

To complement our condensed consolidated statements of operations and comprehensive (loss) income and condensed consolidated statements of cash flows, we use EBITDA, a non-GAAP financial measure. Net (loss) income is the financial measure calculated and presented in accordance with U.S. GAAP that is most directly comparable to EBITDA. We believe EBITDA provides our board of directors, management and investors with a helpful measure for comparing our operating performance with the performance of other companies that have different financing and capital structures or tax rates. We also believe that EBITDA is a measure frequently used by securities analysts, investors and other interested parties in the evaluation of companies in our industry, and is a measure contained in our debt covenants. However, while we consider EBITDA to be an important measure of operating performance, EBITDA and other non-GAAP financial measures have limitations, and investors should not consider them in isolation or as a substitute for analysis of our results as reported under GAAP.

 

 18 

 

 

We define EBITDA as net (loss) income plus interest, income taxes, depreciation and amortization. Net loss was $0.1 million for the three months ended June 30, 2020, as compared to net income of $0.2 million for the three months ended June 30, 2019. EBITDA, a non-GAAP financial measure, was $0.1 million for the three months ended June 30, 2020, as compared to $0.6 million for the three months ended June 30, 2019. The following table provides a reconciliation of EBITDA to net (loss) income, the most directly comparable GAAP measure reported in our condensed consolidated financial statements for the three months ended:

 

(dollars in thousands)  June 30, 2020   June 30, 2019   Change
Amount
 
Net (loss) income  $(116)  $221   $(337)
Income tax (benefit) expense   (37)   90    (127)
Interest expense (1)   58    76    (18)
Depreciation   169    190    (21)
EBITDA  $74   $577   $(503)

 

(1) Includes amortization of debt issue costs.

 

Item 3.  Quantitative and Qualitative Disclosure About Market Risk.

 

As a smaller reporting company, we have elected not to provide the information required by this Item.

 

Item 4. Controls and Procedures.

 

Evaluation of Disclosure Controls and Procedures.

 

Disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act) are controls and procedures that are designed to ensure that the information required to be disclosed in our reports filed or submitted under the Exchange Act, is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms and includes controls and procedures designed to ensure that such information is accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

 

As of the end of the period covered by this report, an evaluation was carried out, under the supervision and with the participation of management, including our Chief Executive Officer and Chief Financial Officer, of the effectiveness of our disclosure controls and procedures. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer concluded that, as of June 30, 2020, our disclosure controls and procedures were effective at a reasonable assurance level.

 

Inherent Limitations Over Internal Controls

 

The Company’s internal control over financial reporting is designed under the supervision of our Chief Executive Officer and Chief Financial Officer, and effected by our board of directors, management and other personnel, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with U.S. GAAP. The Company’s internal control over financial reporting includes those policies and procedures that: (i) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the Company’s assets; (ii) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with GAAP, and that the Company’s receipts and expenditures are being made only in accordance with authorizations of the Company’s management and directors; and (iii) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use, or disposition of the Company’s assets that could have a material effect on the financial statements.

 

Management, including the Chief Executive Officer and Chief Financial Officer, does not expect that the Company’s internal controls will prevent or detect all errors and all fraud. A control system, no matter how well designed and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all control systems, no evaluation of internal controls can provide absolute assurance that all control issues and instances of fraud, if any, have been detected. Also, any evaluation of the effectiveness of controls in future periods is subject to the risk that those internal controls may become inadequate because of changes in business conditions, or that the degree of compliance with the policies or procedures may deteriorate.

 

Changes in Internal Control over Financial Reporting

 

For the quarter ended June 30, 2020, there have been no changes in our internal control over financial reporting that have materially affected or are reasonably likely to materially affect, our internal control over financial reporting.

 

 19 

 

 

PART II. Other Information.

 

Item 6. Exhibits.

 

Exhibit Index

 

Exhibit No.   Description
3.1   Certificate of Incorporation of the Registrant (incorporated herein by reference to Exhibit 3.1 to our registration statement on Form SB-2, filed with the Commission on August 28, 2006).
3.2   Amended and Restated By-laws of the Registrant (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed with the Commission on February 3, 2014).
3.3   Certificate of Designation for Series A Convertible Preferred Stock of the Registrant (incorporated herein by reference to Exhibit 3.1 to our Current Report on Form 8-K, filed with the Commission on March 3, 2006).
3.4   Certificate of Amendment to Certificate of Designation for Series A Convertible Preferred Stock of the Registrant (incorporated herein by reference to Exhibit 3.5 to our Quarterly Report on Form 10-Q, filed with the Commission on November 12, 2009).
10.1   Promissory Note, dated May 8, 2020, made by Ranor Inc.,  (incorporated herein by reference to Exhibit 10.1 to our Current Report on Form 8-K, filed with the Commission on May 14, 2020).
31.1   Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
31.2   Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1   Certification of Chief Executive Officer and Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101   The following financial information from this Quarterly Report on Form 10-Q for the three months ended June 30, 2020, formatted in XBRL (Extensible Business Reporting Language): (i) the Condensed Consolidated Balance Sheets at June 30, 2020 and 2019; (ii) the Condensed Consolidated Statements of Operations and Comprehensive (Loss) Income for the three months ended June 30, 2020 and 2019; (iii) the Condensed Consolidated Statements of Stockholders’ Equity for the years ended June 30, 2020 and 2019; (iv) the Condensed Consolidated Statements of Cash Flows for the three months  ended June 30, 2020 and 2019; and (v) the Notes to the Condensed Consolidated Financial Statements.

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

    TechPrecision Corporation
August 13, 2020 By:  /s/ Thomas Sammons
    Thomas Sammons
    Chief Financial Officer

 

20